Evidence map›Paper›PMID 24075100›Full record

ArticleCytokine2013

The TGFβ1 pathway is required for NFκB dependent gene expression in mouse keratinocytes.

Kelly A Hogan, Anand Ravindran, Michael A Podolsky, Adam B Glick

Open access · greenAbstract read
In one paragraph

Article in Cytokine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Alterations in TGFβ signaling during prostate cancer progression.American journal of clinical and experimental urology · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. miR-200c Modulates the Pathogenesis of Radiation-Induced Oral Mucositis.Oxidative medicine and cellular longevity · 2019
    Article
  13. Review
  14. Article
  15. Signaling Cross Talk between TGF-β/Smad and Other Signaling Pathways.Cold Spring Harbor perspectives in biology · 2017
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kelly A HoganDepartment of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA 16802, USA. Electronic address: kahogan@umich.edu.
Anand Ravindran
Michael A Podolsky
Adam B Glick
Pennsylvania State University · US

Funding

Multi-Media Imagery Program for Breast Cancer Patients (Phase II)R44CA117597 · NCI · MIND MATTERS RESEARCH · PI FREEMAN, LYNDA WELTON · 2008 to 2009
$963k
Training in Animal Models of InflammationT32AI074551 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI GIBLIN, PAMELA A · 2011 to 2015
$940k
A mouse model of TGFbeta1 and tumor immunosurveillance in Squamous cell cancerR01CA117957 · NCI · PENNSYLVANIA STATE UNIVERSITY, THE · PI GLICK, ADAM B · 2006 to 2009
$855k
Multi-Media Imagery Program for Breast Cancer PatientsR43CA117597 · NCI · MIND MATTERS RESEARCH · PI FREEMAN, LYNDA WELTON · 2005 to 2005
$146k
NCI NIH HHS CA117597NCI NIH HHS R01 CA117957NCI NIH HHS R43 CA117597NCI NIH HHS R44 CA117597NIAID NIH HHS T32 AI074551
6 · The paper itself

Abstract

The transforming growth factor-beta 1 (TGFβ1) and NFκB pathways are important regulators of epidermal homeostasis, inflammatory responses and carcinogenesis. Previous studies have shown extensive crosstalk between these pathways that is cell type and context dependent, but this has not been well-characterized in epidermal keratinocytes. Here we show that in primary mouse keratinocytes, TGFβ1 induces NFκB-luciferase reporter activity that is dependent on both NFκB and Smad3. TGFβ1-induced NFκB-luciferase activity was blocked by the IκB inhibitor parthenolide, the IκB super-repressor, a dominant negative TGFβ1-activated kinase 1 (TAK1) and genetic deletion of NFκB1. Coexpression of NFκB p50 or p65 subunits enhanced NFκB-luciferase activity. Similarly, inhibition of the TGFβ1 type I receptor with SB431542 or genetic deletion of Smad3 blocked TGFβ1 induction of NFκB-luciferase. TGFβ1 rapidly induced IKK phosphorylation but did not cause a detectable decrease in cytoplasmic IκB levels or nuclear translocation of NFκB subunits, although EMSA showed rapid NFκB nuclear binding activity that could be blocked by SB431542 treatment. TNFα, a well characterized NFκB target gene was also induced by TGFβ1 and this was blocked in NFκB+/- and -/- keratinocytes and by the IκB super-repressor. To test the effects of the TGFβ1 pathway on a biologically relevant activator of NFκB, we exposed mice and primary keratinocytes in culture to UVB irradiation. In primary keratinocytes UVB caused a detectable increase in levels of Smad2 phosphorylation that was dependent on ALK5, but no significant increase in SBE-dependent gene expression. Inhibition of TGFβ1 signaling in primary keratinocytes with SB431542 or genetic deletion of Tgfb1 or Smad3 suppressed UVB induction of TNFα message. Similarly, UVB induction of TNFα mRNA was blocked in skin of Tgfb1+/- mice. These studies demonstrate that intact TGFβ1 signaling is required for NFκB-dependent gene expression in mouse keratinocytes and skin and suggest that a convergence of these pathways in the nucleus rather than the cytoplasm may be critical for regulation of inflammatory pathways in skin by TGFβ1.

Indexed as

Signal TransductionAnimalsAnimals, NewbornBenzamidesCells, CulturedDioxolesGene ExpressionImmunoblottingKeratinocytesLuciferasesMiceMice, KnockoutNF-kappa BReceptors, Transforming Growth Factor betaReverse Transcriptase Polymerase Chain ReactionSmad3 Protein4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideBenzamidesDioxolesLuciferasesNF-kappa BReceptors, Transforming Growth Factor betaSmad3 ProteinSmad3 protein, mouseTransforming Growth Factor beta1Tumor Necrosis Factor-alphaactivin receptor-like kinase 5ALK5cJun N-terminal kinaseselectrophoretic mobility shift assayEMSAI kappa KinaseαI kappaβI kappaβ super repressorIKKαIKβIKβsrJNKKeratinocyteNFkappaBnuclear factor kappaBSBESmad binding elementsTAK1TGFbeta1TGFβ1TGFβ1 activated kinase 1TNFalphaTNFαtransforming growth factor-beta 1tumor necrosis factor alphaUVB

Identifiers

PMID24075100
PMCPMC3942663
OpenAlexW2004033400

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.